20.10.2016
- German pharmaceutical and chemicals producer Merck KGaA has expanded capacity at its biotech plant in Tres Cantos, Madrid, Spain, by 50% at a cost of €15 million. The facility is...
14.09.2017
- US drugmaker Merck has announced plans to acquire Germany-based Rigontec, regarded as a pioneer in accessing the retinoic acid-inducible gene I (RIG-I) pathway as a novel and...
07.01.2016
- In one of the rare stock launches of a German biotechnology company, industrial biotech firm Brain has announced plans to raise a double-digit sum through an initial public...
17.01.2018
- UK specialty chemicals company Croda has acquired Nautilus Biosciences Canada, a marine biotechnology company based in Charlottetown, Prince Edward Island, Canada. Financial terms...
02.12.2010
- U.S. pharmaceutical company Merck & Co. is set to buy SmartCells Inc, a privately held biotechnology firm in the early stages of developing a new diabetes drug, the Wall Street...
28.03.2014
- U.S. healthcare giant Baxter International has announced plans to split its pharmaceuticals and its medical devices businesses into two publicly traded companies from mid-2015...
The board of directors at US plant-based synthetic biology company Calyxt is evaluating potential strategic alternatives to maximize shareholder value, the company...
14.12.2009
- The issue of control has become a controversial topic in the biotechnology industry as a web of partnerships and joint ventures has complicated several merger negotiations. Bristol...
Specialty pharma company Covis has agreed to buy US-based Amag Pharmaceuticals, boosting its portfolio of therapies for life-threatening conditions and chronic illnesses...
Germany’s Merck said this week it has signed a non-binding Memorandum of Understanding (MoU) with South Korea’s Ministry of Trade, Industry and Energy (MOTIE), and...